Category:

With many ICUs reaching or exceeding maximum capacity in spring 2020 due to the COVID-19 pandemic, it may not be a surprise that about 60% of critical care pharmacists reported feeling burned out in a recent national survey...In an electronic survey that queried critical care pharmacists about their institutions and number of activities performed in May and June 2020, 128 of 221 respondents (58%) reported feelings of burnout such as emotional exhaustion and depersonalization...READ MORE

The U.S. Centers for Medicare and Medicaid Services issued a proposed rule Thursday aimed at improving the electronic exchange of healthcare data among payers, providers and patients...The rule would require Medicaid, CHIP and QHP programs to build HL7 FHIR-based APIs to support data exchange and prior authorization. It also includes a proposed API standard for healthcare operations nationwide...The proposed rule seeks to enhance the patient access API by requiring the use of specific HL7 implementation guides by impacted payers...READ MORE

To help pharmacists advise people on COVID-19 tests, FIP has...issued a guidance document produced by its SARS-CoV-2 Testing Working Group, which has evaluated the diagnostic testing methods and devices currently available...The document covers how different types of diagnostic tests work and the interpretation of results. It also addresses the question of whether or not the presence of antibodies confers immunity to SARS-CoV-2, and makes recommendations on information to give to patients who have tested positive or negative...READ MORE

Despite multiple published guidelines and antimicrobial stewardship programs, inappropriate antibiotic prescribing persists. Can simple behavioral “nudges”—including low-hanging fruit such as tip sheets and posters, as well as default-choice restriction of microbiology lab reports to a list of selected antimicrobials—steer providers in the appropriate direction, thus reducing both the inappropriate use of antibiotics and antibiotic resistance?...READ MORE

• Safety Issues Related to Labeling, Packaging, and Nomenclature
• Safety Issues Associated With Order Communication and Documentation
• Problems Involving Drug Information, Patient Information, Patient Education, and Staff Education
• Safety Issues Related to Medical Devices and Equipment
• Other Discussion Items
• SMP’s Targeted Medication Safety Best Practices for Hospitals...READ MORE

For our 2020 survey, we received 1037 responses from pharmacists. This year undoubtedly posed new challenges for pharmacy amid the coronavirus disease 2019 (COVID-19) pandemic, and our findings underscore the effects...Compensation...pharmacists are still largely making close to what they made in previous years...41% said they received additional income in 2020. The highest earners reported an extra $15,000 or more on average, but most respondents reported between $1001 to $5000 in extra income...Stress and Workload...Management pressure, high work volume, endless amounts of paperwork––all of these are part of a pharmacist’s job...Compounded with the ongoing pandemic and high patient demand, it is no surprise that pharmacists are generally feeling more overwhelmed this year...survey results showed that pharmacists reported higher stress levels and increased workloads in 2020 compared with previous years. Seventy-three percent indicated increased stress levels in 2020 compared with 61% in 2019...READ MORE

A draft NHS England report on overprescribing leaked to HSJ [paywall], proposes that the law should require wider access to healthcare data, in a bid to improve patient safety...The review carried out for health secretary, Matt Hancock, highlights the issue of poor interoperability between NHS computer systems, which means clinicians cannot see or understand what medications patients are taking or when a medication should be reviewed...According to report author, chief pharmaceutical officer Keith Ridge, prescribers should be identified in the electronic health record so they can be contacted by other clinicians. He adds that a free-text box should be created in EHRs so clinicians can explain why a certain medication has been prescribed...READ MORE

Drug manufacturers have had little choice but to act on their own to identify and mitigate the impact of duplicate 340B discounts...Marcy Imada...director at Deloitte & Touche LLP... said preventing duplicate 340B discounts “has proven to be a challenging and long-standing problem for the industry, and in particular for manufacturers. There have been numerous government studies and recommendations provided over the years to try to address this duplicate discounts challenge.”...manufacturers have been left with little choice but to take “more proactive steps” and implement “new strategic initiatives,”... “At least a couple of manufacturers have communicated plans to limit sales at 340B discounted prices billed to a covered entity and shipped to 340B contract pharmacies,” she said...READ MORE

Starting Friday, November 27, 2020, pharmacies must buy and sell only products with a required “product identifier” on their packages. This requirement is part of the phased-in implementation of the Drug Supply Chain Security Act of 2013, also known as the “track-and-trace” law. By Friday, dispensers should be familiar with this requirement and know what to do if a product identifier is not on the package when they receive products that require it. The product identifier is on most drug packages in both human-readable format and on a machine-readable 2D data matrix barcode...“The challenge for dispensers is that not all drug product packages are required to have a product identifier, and there is no central database to check if a product should have one,”...READ MORE

Needs in the European Region in order for pharmacy to deliver breakthroughs for better primary health care are described in a new report...The report summarises the key messages from a conference for the European Region, held by FIP in collaboration the Turkish Pharmacists’ Association in 2019, which facilitated mapping and prioritisation of pharmaceutical practice, service, education and workforce development needs in the context of primary health care. At that conference, pharmacy leaders and pharmacists representing 37 countries in the region committed to deliver better primary health care through pharmacy, and the report presents findings of a survey of FIP member organisations conducted between June and September 2020 to evaluate national pharmacy priorities and strategies towards the implementation of that commitment...READ MORE